C07K 14/8114
Kunitz type inhibitors
Official title: {Kunitz type inhibitors}
C07K14/8114 (Kunitz type inhibitors) appears on 267 US grants and 256 published applications in this corpus.
Search patents in C07K- Granted patents
- 267
- Published applications
- 256
- Assignees
- 147
- Inventors
- 547
- Latest grant
- 8 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1977 | 1 | 0 |
| 1978 | 1 | 0 |
| 1979 | 1 | 0 |
| 1980 | 2 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 1 | 0 |
| 1985 | 0 | 0 |
| 1986 | 1 | 0 |
| 1987 | 0 | 0 |
| 1988 | 1 | 0 |
| 1989 | 0 | 0 |
| 1990 | 3 | 0 |
| 1991 | 1 | 0 |
| 1992 | 4 | 0 |
| 1993 | 7 | 0 |
| 1994 | 4 | 0 |
| 1995 | 10 | 0 |
| 1996 | 6 | 0 |
| 1997 | 9 | 0 |
| 1998 | 21 | 0 |
| 1999 | 14 | 0 |
| 2000 | 10 | 0 |
| 2001 | 18 | 3 |
| 2002 | 11 | 16 |
| 2003 | 11 | 30 |
| 2004 | 6 | 16 |
| 2005 | 8 | 17 |
| 2006 | 13 | 12 |
| 2007 | 6 | 11 |
| 2008 | 4 | 8 |
| 2009 | 8 | 21 |
| 2010 | 6 | 5 |
| 2011 | 6 | 10 |
| 2012 | 7 | 12 |
| 2013 | 8 | 15 |
| 2014 | 7 | 8 |
| 2015 | 13 | 10 |
| 2016 | 4 | 13 |
| 2017 | 10 | 11 |
| 2018 | 5 | 6 |
| 2019 | 4 | 3 |
| 2020 | 4 | 5 |
| 2021 | 2 | 4 |
| 2022 | 1 | 6 |
| 2023 | 2 | 4 |
| 2024 | 1 | 5 |
| 2025 | 2 | 2 |
| 2026 | 3 | 3 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Ulinastatin polypeptides8 Sep 2026US 12,729,233 B2DiaMedica USA Inc.
- Cells, tissues, organs, and animals having one or more modified genes for enhanced xenograft survival and tolerance26 May 2026US 12,637,690 B2eGenesis, Inc.
- Cells, tissues, organs, and animals having one or more modified genes for enhanced xenograft survival and tolerance19 May 2026US 12,630,838 B2eGenesis, Inc.
- Compound for modulating rlr, tlr, oas and/or oncostatin m pathways, use thereof for preparing a medicine, composition, method for modulating said pathways and method of treatment17 Jun 2025US 12,329,806 B2Instituto Butantan
- Inter-alpha inhibitor proteins1 Apr 2025US 12,265,090 B2ProThera Biologics, Inc.
- A modified protein scaffold and use thereof9 Apr 2026US 2026/0098080 A1Evolveritas BiotechnolóGiai KorláTolt FelelosséGu TáRsasáG
- Method for increasing recombinant protein expression9 Apr 2026US 2026/0098271 A1Hoffmann-La Roche Inc.
- Cells, tissues, organs, and animals having one or more modified genes for enhanced xenograft survival and tolerance9 Apr 2026US 2026/0098278 A1eGenesis, Inc.
- Cells, tissues, organs, and animals having one or more modified genes for enhanced xenograft survival and tolerance13 Nov 2025US 2025/0346918 A1eGenesis, Inc.
- Method of treating uveitis with multivalent protein-hyaluronic acid polymer conjugate14 Aug 2025US 2025/0255972 A1Valitor, Inc.
Most cited
By later US patents
- Directed evolution of novel binding proteins2,450US 5,223,409 AProtein Engineering Corporation · 1993
- Viruses expressing chimeric binding proteins1,136US 5,403,484 AProtein Engineering Corporation · 1995
- Directed evolution of novel binding proteins1,057US 5,571,698 AProtein Engineering Corporation · 1996
- Directed evolution of novel binding proteins286US 5,837,500 ADyax Corp. · 1998
- Methods for producing heterologous disulfide bond-containing polypeptides in bacterial cells160US 6,083,715 ABoard of Regents, The University of Texas System · 2000